Back
Day Range
$54.29
$56.66
52-Week Range
$26.74
$63.95
Volume
1,536,325
50D / 200D Avg
$45.08
/
$39.69
Prev Close
$54.94
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.1 | 0.4 |
| P/B | 7.8 | 2.9 |
| ROE % | -51.8 | 3.7 |
| Net Margin % | -4612.1 | 3.9 |
| Rev Growth 5Y % | -20.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$76.67
+40.9%
Low: $44.00
High: $100.00
Forward EPS
-$4.80
Est. Revenue
4.4 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$5.26
-$0.12 – $14.65
|
1.3 B | 5 |
| FY2029 |
$1.59
-$0.04 – $4.43
|
790 M | 11 |
| FY2028 |
-$2.95
-$5.82 – $1.54
|
280 M | 13 |
Key Takeaways
Revenue declined -20.14% annually over 5 years
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -279.92M
Growth
Revenue Growth (5Y)
-20.14%
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-51.76%
ROIC-47.45%
Net Margin-4612.13%
Op. Margin-4974.27%
Safety
Debt / Equity
0.01
Current Ratio13.42
Interest Coverage0.00
Valuation
P/E Ratio
-13.09
P/B Ratio7.78
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20.14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7.50M | Net Income (TTM) | -345.91M |
| ROE | -51.76% | ROA | -35.24% |
| Gross Margin | 66.09% | Operating Margin | -4974.27% |
| Net Margin | -4612.13% | Free Cash Flow (TTM) | -279.92M |
| ROIC | -47.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 13.42 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.09 | P/B Ratio | 7.78 |
| P/S Ratio | 603.63 | PEG Ratio | -0.23 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.53B | Enterprise Value | 4.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.50M | 0.0 | 0.0 | 9.43M | 18.44M |
| Net Income | -345.91M | -234.33M | -182.39M | -125.37M | -78.88M |
| EPS (Diluted) | -4.36 | -3.01 | -2.73 | -2.06 | -1.77 |
| Gross Profit | 4.96M | -2.56M | -167.51M | 9.43M | 18.44M |
| Operating Income | -373.07M | -279.30M | -214.05M | -129.14M | -78.99M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 981.67M | 798.14M | 964.80M | 754.15M | 572.01M |
| Total Liabilities | 399.91M | 43.24M | 36.88M | 32.65M | 21.97M |
| Shareholders' Equity | 581.76M | 754.90M | 927.92M | 721.50M | 550.03M |
| Total Debt | 7.94M | 9.02M | 10.90M | 10.44M | 8.26M |
| Cash & Equivalents | 199.16M | 142.71M | 148.64M | 57.24M | 175.69M |
| Current Assets | 560.65M | 635.26M | 644.96M | 600.30M | 559.02M |
| Current Liabilities | 41.79M | 35.59M | 27.27M | 22.70M | 14.32M |